This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chida, K. Articles by Kuroki, T. Search for Related Content PubMed PubMed Citation Articles by Chida, K. Articles by Kuroki, T.

Inhibition by 1,-25-Dihydroxyvitamin D₃ of Induction of Epidermal Ornithine Decarboxylase Caused by 12-O-Tetradecanoylphorbol-13-acetate and Teleocidin B¹

Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108 [K. C., H. H., T. K.], and Department of Biochemistry, School of Dentistry, Showa University, Hatanodai, Shinagawa-ku, Tokyo 142 [T. S.], Japan

Topical application of 1,25-dihydroxyvitamin D₃ [1,25-(OH)₂D₃], an active form of vitamin D₃, markedly inhibited induction of ornithine decarboxylase caused by 12-O-tetradecanoylphorbol-13-acetate (TPA) and teleocidin B in mouse skin. The degree of inhibition was dependent on the dose and time of application of 1,25(OH)₂D₃. Application of 1 µg 1,25(OH)₂D₃ within 30 min before or after treatment with 10 µg TPA caused about 72% inhibition of ODC induction at 4 hr. Similar degrees of inhibition were obtained with dose ratios of 1,25(OH)₂D₃ to TPA of 1:3, 1:10, and 1:30. The dose required for 50% inhibition was 0.063 µg, or 0.15 nmol, which is about one-half that of retinoic acid, a known inhibitor of induction of ODC activity by TPA. 1,25(OH)₂D₃ had a specific inhibitory effect, in which 100 times higher doses or more of other derivatives of vitamin D₃, such as 1-hydroxyvitamin D₃, 25-hydroxyvitamin D₃, 24R,25-dihydroxyvitamin D₃, and vitamin D₃, were required to inhibit ODC induction by TPA. 1,25(OH)₂D₃ did not inhibit epidermal hyperplasia induced by TPA.

¹ Supported in part by a grant for Cancer Research from the Ministry of Education, Science and Culture of Japan.

² To whom requests for reprints should be addressed.

Received 9/ 7/83. Accepted 12/28/83.

This article has been cited by other articles:

				T. W. Kensler, P. M. Dolan, S. J. Gange, J.-K. Lee, Q. Wang, and G. H. Posner Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis Carcinogenesis, July 1, 2000; 21(7): 1341 - 1345. [Abstract] [Full Text] [PDF]